Google launchedDeepMind Health, a medical vertical of the London-based AI powerhouse that Google acquired for $550 million or so in 2014. Their first offerings include Streams, an app to help doctors and nurses detect acute kidney injury, and Hark, a clinical task management app that Google says increased clinician response times by 37% over pagers.
A Commonwealth Fund study of 1,046 health apps addressing chronic illnesses found that “43% of iOS apps and 27% of Android apps appeared likely to be useful.” They offer a breakdown of why apps were struck from the “useful” list and give a few examples of good ones, including Mango Health’s adherence app.
The failure of physicians to disclose ties to pharmas when plugging drugs over social media was put under a harsh spotlight by Stat. There’s no “Sunshine Act”-style provision mandating disclosure for Tweets and such, though the Massachusetts Medical Society recently required that all members divulge any financial relationships relevant to products and services discussed online.
This week in election year grandstanding: a bill that would ban consumer advertising of prescription drugs unless they are determined to have “affirmative value” to public health is moving through Congress. It has virtually zero chance of passage and would be challenged on First Amendment grounds, but it will make for more political theater.
Speaking of that precision medicine push, some good news on that front – “Big companies are falling over each other to claim to be more open, and to collect patient data, to share it and to give patients a voice in the process,” writes Forbes’ Matthew Herper.
Point: “In recent months, however, there has been a growing sense on Madison Avenue that digital advertising doesn’t always move the needle on sales. The precision advertisers get with commercials delivered via the Web and mobile devices is welcome and allows big marketers to aim more finely at consumer bases, but some form of TV advertising remains necessary to move mass quantities of product. In 2016, there is a growing sense on Wall Street and among media companies that the coming TV upfront market could be healthier than it has been in several years, with advertisers committing more money to TV in advance than has been typical.”
Counterpoint: “With these changes coming to healthcare from precision medicine, it may no longer be acceptable to do generic or broad marketing campaigns in hopes of catching the small group of people who may benefit from a device or treatment.”